ZEPP· Information Technology› Consumer Electronics

Zepp Health Corporation Class A

Stage 4 · Declining · week 35

As of Oct 22, 2026, Zepp Health is in Stage 4, the downtrend phase, now in week 35 (since Feb 17, 2026). It closed at $2.66, 94.6% below its 52-week high and below its 200-day average, which is falling.

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. More about the company

$2.66

-3.62% today

$39.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is ZEPP early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 23w

S4 14w

S2 17w

S3 13w

S4 35w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 1w → S1 7w → S4 7w → S1 3w → S2 9w → S3 5w → S4 23w → S1 10w → S2 1w → S1 1w → S3 2w → S4 14w → S1 1w → S2 2w → S1 1w → S4 12w → S1 1w → S2 17w → S3 13w → S4 35w current

Total tracked: 165 weeks across 20 stage runs.

ZEPP among Consumer Electronics16th of 19 by relative strength

All 19 →

Stocks in Consumer Electronics ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AAPLApple Inc.	Stage 2 · wk 24	78	+3.3%
2	UEICUniversal Electronics Inc.	Stage 2 · wk 15	72	−3.6%
3	SONOSonos, Inc.	Stage 2 · wk 6	59	+3.6%
4	TBCHTurtle Beach Corporation	Stage 2 · wk 3	55	+28.7%
5	SONYSony Group Corporation	Stage 2 · wk 7	46	+12.9%
6	AXILAXIL Brands, Inc.	Stage 1 · wk 4	45	−6.6%
7	FEBOFenbo Holdings Limited Class A	Stage 4 · wk 16	45	−9.6%
8	KOSSKoss Corporation	Stage 1 · wk 2	30	−11.9%
…16	ZEPPZepp Health Corporation Class A	Stage 4 · wk 35	5	−37.3%

vs 52W High

-94.6%

$2.66 lo$48.88 hi

94.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 35

1w13w26w

Week 35, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-75.6%

200 DMA: $10.89 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.13x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-37.3%

-45.7%

-83.9%

YTD

-90.5%

-94.6%

Scan Membership

Breakout Watch

Latest: 2025-03-21

8 appearances in last 60 days. First seen: 2019-01-30.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 35 · Vol 1.13x

2026-10-21S4

Wk 35 · Vol 1.59x

2026-10-20S4

Wk 35 · Vol 3.91x

2026-10-19S4

Wk 34 · Vol 2.55x

2026-10-16S4

Wk 34 · Vol 0.93x

2026-10-15S4

Wk 34 · Vol 1.13x

2026-10-14S4

Wk 34 · Vol 0.46x

2026-10-13S4

Wk 34 · Vol 0.97x

2026-10-12S4

Wk 33 · Vol 0.70x

2026-10-09S4

Wk 33 · Vol 0.24x

2026-10-08S4

Wk 33 · Vol 0.21x

2026-10-07S4

Wk 33 · Vol 0.23x

Moving averages & range

50 DMA

$4.33

200 DMA

$10.89

52W High

$48.88

52W Low

$2.66

5D Low

$2.66

Resistance levels (recent highs)

20d High

$4.14

60d High

$5.82

120d High

$18.01

250d High

$46.00

Next resistance

+55.6%

to 20d High

ROE

-21.2%

Profit margin -15.8%

Dividend Yield

0.00%

P/B 0.2

Zepp Health: quick answers

What stage is Zepp Health in?

As of Oct 22, 2026, Zepp Health (ZEPP) is in Stage 4, the downtrend phase. It entered Stage 4 on Feb 17, 2026 and is in week 35. What the four stages mean

Is Zepp Health in an uptrend?

No. Zepp Health is in a Stage 4 downtrend. It trades 75.6% below its 200-day average, which is falling.

How far is Zepp Health from its 52-week high?

Zepp Health closed at $2.66 on Oct 22, 2026, 94.6% below its 52-week high of $48.88. Its 52-week low is $2.66.

How has Zepp Health performed over the past year?

As of Oct 22, 2026, Zepp Health is down 94.6% over the past year and down 90.5% so far in 2026.

Which sector and industry is Zepp Health in?

Zepp Health is in the Consumer Electronics industry, part of the Information Technology sector.

About this companyInformation Technology· Consumer Electronics

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 150 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.